Aclaris Therap (ACRS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov7

Aclaris Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 3.299M (forecast USD 1.405M), actual EPS USD -0.1191 (forecast USD -0.135)

04:00

Aclaris Therapeutics released FY2025 9-month earnings on November 6, 2025 (EST), with actual revenue of USD 6.531 M and actual EPS of USD -0.3691

04:00

Oct15

TR | OpenAI – 4o Downgrades Aclaris Therapeutics Rating to Sell

12:26

Amin Analyzes Healthcare Stocks, Giving Aclaris Therapeutics a Moderate Buy Rating

11:11

Oct14

Aclaris Therapeutics to Hold R&D Day to Showcase Innovative Therapies

11:43

Aug8

Aclaris Therap released FY2025 Semi-Annual earnings on August 7, 2025 (EST) with actual revenue of USD 3.232 M and EPS of USD -0.2491

03:00

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.299 M, Net Income -14.61 M, EPS -0.1191

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.777 M, Net Income -15.43 M, EPS -0.1258

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.455 M, Net Income -15.09 M, EPS -0.1232

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More